Groove Botanicals Files Draft Information Statement

• Groove Botanicals shareholders authorized up to $15 million in Series C Preferred Stock on October 20, 2026.
• The shares carry a 7% non-cumulative annual dividend, with conversion into Common Stock at a 25% discount to the trailing market price.
• Conversions could substantially dilute Common Stock holders but will remain suspended until sufficient authorized shares are available.
• Shareholders also authorized restrictions on redeeming Series A Convertible Preferred Stock without holder consent, preserving Kent Rodriguez's approximately 51% voting control.
• Both actions are expected to take effect on or about November 20, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Groove Botanicals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-26-006343), on October 20, 2026, and is solely responsible for the information contained therein.